The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
For those of you that are not familiar with neuromodulators, these are similar to neurotransmitters, but they tend to act more broadly. They tend to impact many more neurons all at once and they go by names like dopamine, serotonin, acetylcholine, epinephrine, and so forth.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
dopamine is broadly involved in motivation craving and pursuit and norepinephrine and Signal detection and drawing of focus or salience to something in our environment or in our body or inner experience
And those neuromodulators have names that probably you've heard of before, things like dopamine, and serotonin, and acetylcholine, epinephrine. Neuromodulators are really interesting because they bias which neurons are likely to be active and which ones are likely to be inactive.